Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Stock data | 2023 | Change |
---|---|---|
Price | $490.00 | N/A |
Market Cap | $172.52B | N/A |
Shares Outstanding | 352.07M | -1.02% |
Employees | 12.12K | N/A |
Shareholder Equity | 13.40B | 20.56% |
Valuation | 2023 | Change |
---|---|---|
P/S Ratio | 24.22 | N/A |
P/B Ratio | 12.88 | N/A |
P/FCF | 230.14 | N/A |
POE | 0.00 | N/A |
Growth | 2023 | Change |
---|---|---|
ROIC | 0.2043 | N/A |
CAPEX | -1.06B | N/A |
Return on Equity | 0.1356 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $7.12B | N/A |
Earnings | $1.82B | N/A |
Free Cash Flow | $749.60M | N/A |
Gross Margin | 0.6639 | N/A |
Operating Margin | 0.248 | N/A |
Net income margin | 0.2551 | N/A |
FCF Margin | 0.1052 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $15.44B | N/A |
Cash on Hand | $5.22B | N/A |
Debt to Equity | 0.1526 | -8.91% |
POE | 0.0000 | N/A |
Current Ratio | $4.76 | 8.15% |
Other data | 2023 | Change |
---|---|---|
Buyback Yield | 0.0024 | N/A |